Terms: = Sarcomas AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
2132 results:
1. Radiolabelled FGF-2 for Imaging Activated Fibroblasts in the Tumor Micro-Environment.
Bentivoglio V; Galli F; Varani M; Ranieri D; Nayak P; D'Elia A; Soluri A; Massari R; Lauri C; Signore A
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672507
[TBL] [Abstract] [Full Text] [Related]
2. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
[TBL] [Abstract] [Full Text] [Related]
3. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways.
Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
[TBL] [Abstract] [Full Text] [Related]
4. Teacher-student collaborated multiple instance learning for pan-cancer PDL1 expression prediction from histopathology slides.
Jin D; Liang S; Shmatko A; Arnold A; Horst D; Grünewald TGP; Gerstung M; Bai X
Nat Commun; 2024 Apr; 15(1):3063. PubMed ID: 38594278
[TBL] [Abstract] [Full Text] [Related]
5. A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers.
Kenney RT; Cini JK; Dexter S; DaFonseca M; Bingham J; Kuan I; Chawla SP; Polasek TM; Lickliter J; Ryan PJ
Front Immunol; 2024; 15():1362775. PubMed ID: 38487528
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
Ruan GJ; Zanwar S; Ravindran A; Schram S; Abeykoon JP; Hazim A; Young JR; Shah MV; Bennani NN; Jiang L; Morlote D; Rech KL; Goyal G; Go RS;
Am J Hematol; 2024 May; 99(5):871-879. PubMed ID: 38409747
[TBL] [Abstract] [Full Text] [Related]
7. Doxorubicin loaded octacalcium phosphate particles as controlled release drug delivery systems: Physico-chemical characterization, in vitro drug release and evaluation of cell death pathway.
Kovrlija I; Pańczyszyn E; Demir O; Laizane M; Corazzari M; Locs J; Loca D
Int J Pharm; 2024 Mar; 653():123932. PubMed ID: 38387818
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer.
Rönnlund C; Sifakis EG; Schagerholm C; Yang Q; Karlsson E; Chen X; Foukakis T; Weidler J; Bates M; Fredriksson I; Robertson S; Hartman J
Breast Cancer Res; 2024 Feb; 26(1):24. PubMed ID: 38321542
[TBL] [Abstract] [Full Text] [Related]
9. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common
Lim WC; Marques Da Costa ME; Godefroy K; Jacquet E; Gragert L; Rondof W; Marchais A; Nhiri N; Dalfovo D; Viard M; Labaied N; Khan AM; Dessen P; Romanel A; Pasqualini C; Schleiermacher G; Carrington M; Zitvogel L; Scoazec JY; Geoerger B; Salmon J
Front Immunol; 2023; 14():1265469. PubMed ID: 38318504
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2.
Nie X; Fan J; Dai B; Wen Z; Li H; Chen C; Wang DW
Circ Res; 2024 Feb; 134(4):425-441. PubMed ID: 38299365
[TBL] [Abstract] [Full Text] [Related]
11. Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial.
Cho HJ; Yun KH; Shin SJ; Lee YH; Kim SH; Baek W; Han YD; Kim SK; Ryu HJ; Lee J; Cho I; Go H; Ko J; Jung I; Jeon MK; Rha SY; Kim HS
Nat Commun; 2024 Jan; 15(1):685. PubMed ID: 38263321
[TBL] [Abstract] [Full Text] [Related]
12. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
[TBL] [Abstract] [Full Text] [Related]
13. Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma.
Hu EY; Bhagavatula SK; Shi A; Merriam P; Levesque VM; Shyn PB
Abdom Radiol (NY); 2024 Apr; 49(4):1241-1247. PubMed ID: 38240859
[TBL] [Abstract] [Full Text] [Related]
14. A study of collagen refractility in dermatofibroma and dermatofibrosarcoma protuberans using diffractive microscopy.
Brailsford C; Khamdan F; Dirr MA; Sagut P; Nietert PJ; Elston D
J Cutan Pathol; 2024 Apr; 51(4):306-310. PubMed ID: 38124386
[TBL] [Abstract] [Full Text] [Related]
15. New copper(II) and oxidovanadium(IV) complexes with a vitamin B
Balsa LM; Ferretti V; Sottile M; Nunes P; Costa Pessoa J; Correia I; León IE
Dalton Trans; 2024 Feb; 53(7):3039-3051. PubMed ID: 38111362
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
Rajdev L; Jackie Wang CC; Joshi H; Lensing S; Lee J; Ramos JC; Baiocchi R; Ratner L; Rubinstein PG; Ambinder R; Henry D; Streicher H; Little RF; Chiao E; Dittmer DP; Einstein MH; Cesarman E; Mitsuyasu R; Sparano JA;
Cancer; 2024 Mar; 130(6):985-994. PubMed ID: 37962072
[TBL] [Abstract] [Full Text] [Related]
17. Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
Rosenberg SM; McCue S; He J; Lafky JM; Carey LA; Galanis E; Leonard JP; Meyerhardt J; Ng K; Schwartz GK; Stock W; Paskett ED; Partridge AH; George S
Cancer; 2024 Mar; 130(5):750-769. PubMed ID: 37916800
[TBL] [Abstract] [Full Text] [Related]
18. Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.
Kitadai R; Nishikawa T; Yoshida H; Mizoguchi C; Yamamoto K; Kato T; Yonemori K
J Gynecol Oncol; 2024 Mar; 35(2):e11. PubMed ID: 37914528
[TBL] [Abstract] [Full Text] [Related]
19. Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A.
Martin-Broto J; Martinez-Garcia J; Moura DS; Redondo A; Gutierrez A; Lopez-Pousa A; Martinez-Trufero J; Sevilla I; Diaz-Beveridge R; Solis-Hernandez MP; Carnero A; Perez M; Marcilla D; Garcia-Foncillas J; Romero P; Fernandez-Jara J; Lopez-Lopez D; Arribas I; Hindi N
Signal Transduct Target Ther; 2023 Oct; 8(1):405. PubMed ID: 37875500
[TBL] [Abstract] [Full Text] [Related]
20. Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.
Villanueva G; Lowe J; Tentoni N; Taluja A; Villarroel M; Narváez CE; León SA; Valencia Libreros DL; Gonzalez Suárez N; Mikkelsen TS; Howard SC
Pediatr Hematol Oncol; 2024; 41(2):135-149. PubMed ID: 37865916
[TBL] [Abstract] [Full Text] [Related]
[Next]